ALSO NOTED: Nastech hit on missed payment; Nastech announces Phase I data;and much more...

> Shares of Nastech Pharmaceuticals took a beating yesterday after P&G failed to make a scheduled $15 million payment in 2006. The two companies are collaborating on a nasal spray for osteoporosis. Report

> Today Nastech announced positive Phase I data on its insulin nasal spray. Release

> Solvay and Wyeth Pharmaceuticals are touting new Phase II and III data which supports the efficacy of its antipsychotic drug bifeprunox in comparison with a placebo. Report

> Tucson-based ImaRX has pulled its IPO, citing weak market conditions. Report

> Canada's ProMetic Life Sciences has pulled its IPO as well, saying that higher 2007 revenue will make the company worth more than it could expect from a public float. Report

> Migenix has raised $11.6 million in bought-deal financing. Release

And Finally... In a small number of cases, parents are using genetic screening to select embryos with defects like their own. Article